The FDA has granted Spino Modulation (a Spinologics subsidiary) a “Breakthrough Device Designation” for our MIScoli(TM) system
![](https://www.spinologics.ca//wp-content/uploads/2021/09/spinologics-logo-2020-1.jpg)
The FDA has granted Spino Modulation (a Spinologics subsidiary) a “Breakthrough Device Designation” for our MIScoli(TM) system